HOME >> MEDICINE >> NEWS
Home blood pressure monitoring helps patients manage hypertensive drug treatments

Patients who monitored their blood pressure at home were able to decrease blood pressure medication and slightly lower their costs, according to a study in the February 25 issue of The Journal of the American Medical Association (JAMA).

Jan A. Staessen, M.D., Ph.D., from University of Leuven, Leuven, Belgium, and colleagues from the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators, compared self-measurement and conventional office measurement of blood pressure in the treatment of patients with hypertension (high blood pressure). The study included 400 patients with a diastolic blood pressure (the lower number in the blood pressure measurement, such as for a blood pressure of 140/80, the diastolic pressure is 80) reading of 95 mm Hg (millimeters of mercury) or more as measured at physicians' offices and then randomized them to receive antihypertensive drug treatment based on office blood pressure readings (n=197) or home blood pressure readings (n=203). The study took place between March 1997 to April 2002 in Belgium and Dublin, Ireland. The participants recorded several (usually 6) home measurements a day and averaged the daily BP over one week. The other group's measurements were averaged from three readings at the physicians' office. The patients were followed up for one year.

"At the end of the study, more home BP (blood pressure) than office BP patients had stopped antihypertensive drug treatment (25.6 percent vs. 11.3 percent) with no significant difference in the proportions of patients progressing to multiple-drug treatment (38.7 percent vs. 45.1 percent)," the researchers found. "The final office, home, and 24-hour ambulatory BP measurements were higher in the home BP group than in the office BP group."

"In conclusion, adjustment of antihypertensive treatment based on home BP instead of office BP led to less-intensive drug treatment and marginally lower costs but also to
'"/>

Contact: Jan A. Staessen, M.D., Ph.D.
jan.staessen@med.kuleuven.ac.be
JAMA and Archives Journals
24-Feb-2004


Page: 1 2

Related medicine news :

1. A marker for new blood vessel formation in tumors
2. Acupuncture found to lower elevations in blood pressure
3. Diagnostic test for range of blood disorders on the horizon
4. Research suggests possible blood test for multiple sclerosis
5. Epstein-Barr virus protein crucial to its role in blood cancers
6. Simple blood test may help to predict cardiovascular risk in older women
7. Drug that hinders blood vessel growth under study in ovarian cancer
8. Laughter helps blood vessels function better
9. St. Johns wort amplifies effect of blood thinner Plavix
10. Latest findings on genetic blood disorder Cooleys Anemia
11. Can routine commercial cord blood banking be scientifically and ethically justified?

Post Your Comments:
(Date:5/20/2013)... (PRWEB) May 20, 2013 This summer, ... the world will make the pilgrimage to San Diego, ... annual Digital Health Summer Summit produced by ... a unique forum to showcase the latest digital health ... practices, and network with some of industry’s most brilliant ...
(Date:5/20/2013)... May 20, 2013 For more than ... waged a battle against drug and alcohol abuse around ... released its first guide to help Italian speakers reverse ... by the European Monitoring Centre for Drugs and Drug ... have used cannabis in the last year. As a ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... What is it about toothpaste that transforms the sweet ... the solution to that mysterious sensory phenomenon in ... the American Chemical Society,s award-winning Bytesize Science ... from the world,s largest scientific society, explains that the ... lauryl sulfate, or SLS for short. When you brush ...
(Date:5/20/2013)... MAYWOOD, Il. - Nearly three out of ... disorders during their pregnancies, a Loyola University Medical Center ... only minimal impacts on pregnant women,s quality of life, ... Scott Graziano, MD and Payton Johnson was presented during ... Clinical Meeting in New Orleans. , One hundred and ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/19/2013)... ORLANDO, Fla. , May 19, 2013 /PRNewswire/ ... power and low temperature radiofrequency (RF) energy is ... and eliminates or reduces the need for medication ... long-term assessment presented today at the Digestive Disease ... Orlando, Florida . ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
Cached News: